February 7, 2012
LA JOLLA, CA AND IPSWICH, MA, Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and New England Biolabs, Inc. (NEB), today jointly announced that they have entered into a non-exclusive licensing agreement whereby NEB will commercialize the Gibson Assembly™ Master Mix. This product [...]
Introducing ATCC Tumor Cell Panels: Powerful New Tools for Cancer Research
February 7, 2012
Searching for appropriate tumor cell models often entails a time-intensive review of the literature and genomic databases. To enable cancer researchers, ATCC (American Type Culture Collection) has introduced a collection of Tissue-Specific Tumor Cell Panels. These powerful new tools combine well-characterized adherent cell lines that were selected for their genomic mutations as found in the [...]
Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
February 7, 2012
CARLSBAD, Calif., Life Technologies Corporation (NASDAQ: LIFE) today announced results for the quarter and full year ended December 31, 2011 and provided financial guidance for 2012. "I am pleased with our performance in the fourth quarter and throughout 2011, even as we faced a number of challenges, including macroeconomic headwinds and constrained spending by some [...]
Alfa Laval AB (publ) Fourth quarter and full year 2011
February 7, 2012
“Order intake during the fourth quarter was SEK 6.8 billion, an increase with 6 percent compared to the corresponding quarter 2010. Compared to the third quarter order intake decreased with 15 percent, influenced by a lower demand from the shipbuilding industry and an awaiting attitude to making decisions concerning projects by certain customers. Order intake [...]
Brooks Life Science Systems and The Scripps Research Institute Initiate Partnership
February 7, 2012
POWAY, CA, Brooks Life Science Systems, a division of Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide provider of automation solutions for compound and biological sample storage and management, today announced the initiation of a technology development and commercialization partnership with The Scripps Research Institute (Scripps Research). The cornerstone of this partnership will be an exclusive [...]
NANOINK ANNOUNCES LAUNCH OF CONTRACT SERVICES PROGRAM FOR LIVE SINGLE CELL ASSAY WORK
February 7, 2012
CHICAGO, IL, NanoInk's® NanoFabrication Systems Division announced today that it introduced a new contract services program dedicated to the development of live single cell array assays. This offering supplements NanoInk's portfolio of Dip Pen Nanolithography® (DPN®)-based systems and tools used for micro and nanopatterning applications to include a service component. Life scientists now have even [...]
February 7, 2012
Glasgow, UK, Sistemic is delighted to announce that its proprietary technology (SistemQC™) has been chosen to form a key part of the research and production process for a landmark multinational collaborative project led by TiGenix, Belgium and including partners from Spain, France, the Netherlands as well as the UK and Belgium. The project, REGENER-AR, will [...]
February 7, 2012
Naarden, The Netherlands, BAC BV, the leading provider of antibody-based affinity purification technology together with Life Technologies Corporation has announced the launch of a range of POROS® CaptureSelect® affinity columns. By combining BAC’s CaptureSelect affinity ligand technology with Life Technologies’ POROS resin, the companies now offer a platform for high speed, high performance product-specific process [...]
Genome Designs, Inc. Receives Seed Financing and Starts Operation
February 7, 2012
WALNUT CREEK, CA, Genome Designs, Inc. today announced that it has received seed financing from undisclosed private investors and started operation. Founded by veterans of Argonne National Lab, NCBI, Integrated Genomics and Ariadne, the company is taking on the challenge of functional annotation of the next-generation sequencing projects for the life science community. "Our long-term [...]
February 7, 2012
SAN DIEGO, Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that its Board of Directors thoroughly reviewed Roche’s unsolicited tender offer with the assistance of its financial and legal advisors and unanimously determined that the $44.50 per share [...]

